BNTC Benitec Biopharma Inc.
$9.04
Benitec Biopharma Inc. (BNTC) is confirmed to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.31 per share.
Benitec Biopharma Beat Consensus Estimates
Friday, November 13, 2026 · 8:00 AM ET
Earnings Date
2nd Quarter, Dec 2026
Nov 13
Friday · Before Open
Earnings Whisper
-
vs ($0.31)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$9.35
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Benitec Biopharma Inc.
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines.
Sector
Healthcare
Industry
Biotechnology
Held By 1 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.